SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-040833
Filing Date
2008-07-02
Accepted
2008-07-02 17:26:01
Documents
1
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4115
  Complete submission text file 0001209191-08-040833.txt   6013
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address (650) 266-3500
Pierce Valerie L (Reporting) CIK: 0001397112 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 08935567